Catheter Precision (VTAK) said Tuesday it has received CE Mark approval for its vascular closure device LockeT.
The company said it can now offer the LockeT device, registered with the US Food and Drug Administration, in EU regions and additional markets, including the UK, Switzerland, and Turkey.
The medical device company said it has received its first order for 100 units from the EU.
Shares of Catheter Precision were down past 13% in recent Tuesday trading.
Price: 0.21, Change: -0.03, Percent Change: -13.42
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.